Berchuck A - Search Results

1

Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors.

Schildkraut JM, Iversen ES, Akushevich L, Whitaker R, Bentley RC, Berchuck A, Marks JR. Schildkraut JM, et al. Among authors: berchuck a. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1709-21. doi: 10.1158/1055-9965.EPI-13-0192. Epub 2013 Aug 5. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23917454 Free PMC article.

2

Ha-ras polymorphisms in epithelial ovarian cancer.

O'Briant K, Chrysson N, Hunter V, Tyson F, Tanner M, Daly L, George SL, Berchuck A, Soper J, Fowler W, et al. O'Briant K, et al. Among authors: berchuck a. Gynecol Oncol. 1992 Jun;45(3):299-302. doi: 10.1016/0090-8258(92)90308-6. Gynecol Oncol. 1992. PMID: 1351862

3

The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells.

Boente MP, Berchuck A, Rodriguez GC, Davidoff A, Whitaker R, Xu FJ, Marks J, Clarke-Pearson DL, Bast RC Jr. Boente MP, et al. Among authors: berchuck a. Am J Obstet Gynecol. 1992 Dec;167(6):1877-82. doi: 10.1016/0002-9378(92)91790-h. Am J Obstet Gynecol. 1992. PMID: 1361720

4

Ploidy analysis of epithelial ovarian cancers using image cytometry.

Berchuck A, Boente MP, Kerns BJ, Kinney RB, Soper JT, Clarke-Pearson DL, Bast RC Jr, Bacus SS. Berchuck A, et al. Gynecol Oncol. 1992 Jan;44(1):61-5. doi: 10.1016/0090-8258(92)90013-9. Gynecol Oncol. 1992. PMID: 1370427

5

Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery.

Rodriguez GC, Soper JT, Berchuck A, Oleson J, Dodge R, Montana G, Clarke-Pearson DL. Rodriguez GC, et al. Among authors: berchuck a. J Clin Oncol. 1992 Oct;10(10):1553-60. doi: 10.1200/JCO.1992.10.10.1553. J Clin Oncol. 1992. PMID: 1383433

6

Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer.

Olt G, Berchuck A, Soisson AP, Boyer CM, Bast RC Jr. Olt G, et al. Among authors: berchuck a. Cancer. 1992 Oct 15;70(8):2137-42. doi: 10.1002/1097-0142(19921015)70:8<2137::aid-cncr2820700821>3.0.co;2-w. Cancer. 1992. PMID: 1394043

7

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, Humphrey P, Berchuck A, Ponder BA, Bast RC Jr. Jacobs IJ, et al. Among authors: berchuck a. J Natl Cancer Inst. 1992 Dec 2;84(23):1793-8. doi: 10.1093/jnci/84.23.1793. J Natl Cancer Inst. 1992. PMID: 1433368

8

Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta.

Berchuck A, Rodriguez G, Olt G, Whitaker R, Boente MP, Arrick BA, Clarke-Pearson DL, Bast RC Jr. Berchuck A, et al. Am J Obstet Gynecol. 1992 Feb;166(2):676-84. doi: 10.1016/0002-9378(92)91697-9. Am J Obstet Gynecol. 1992. PMID: 1536252

9

Overexpression and mutation of p53 in endometrial carcinoma.

Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC Jr, Marks JR. Kohler MF, et al. Among authors: berchuck a. Cancer Res. 1992 Mar 15;52(6):1622-7. Cancer Res. 1992. PMID: 1540970

10

p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry.

Kerns BJ, Jordan PA, Moore MB, Humphrey PA, Berchuck A, Kohler MF, Bast RC Jr, Iglehart JD, Marks JR. Kerns BJ, et al. Among authors: berchuck a. J Histochem Cytochem. 1992 Jul;40(7):1047-51. doi: 10.1177/40.7.1607637. J Histochem Cytochem. 1992. PMID: 1607637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

640 results

Search Page

Filters